Open access · CC-BY
via OpenAlex
Astaxanthin as a Putative Geroprotector: Molecular Basis and Focus on Brain Aging
Vincenzo Sorrenti, Sergio Davinelli, Giovanni Scapagnini, Bradley J. Willcox, Richard Allsopp, D. Craig Willcox
Marine Drugs · 2020 · ▲ 63 citations
Abstract
In recent years, the scientific interest in natural compounds with geroprotective activities has grown exponentially. Among the various naturally derived molecules, astaxanthin (ASX) represents a highly promising candidate geroprotector. By virtue of the central polyene chain, ASX acts as a scavenger of free radicals in the internal membrane layer and simultaneously controls oxidation on the membrane surface. Moreover, several studies have highlighted ASX's ability to modulate numerous biological mechanisms at the cellular level, including the modulation of transcription factors and genes directly linked to longevity-related pathways. One of the main relevant evolutionarily-conserved transcription factors modulated by astaxanthin is the forkhead box O3 gene (FOXO3), which has been recognized as a critical controller of cell fate and function. Moreover, FOXO3 is one of only two genes shown to robustly affect human longevity. Due to its tropism in the brain, ASX has recently been studied as a putative neuroprotective molecule capable of delaying or preventing brain aging in different experimental models of brain damage or neurodegenerative diseases. Astaxanthin has been observed to slow down brain aging by increasing brain-derived neurotrophic factor (BDNF) levels in the brain, attenuating oxidative damage to lipids, protein, and DNA and protecting mitochondrial functions. Emerging data now suggest that ASX can modulate Nrf2, FOXO3, Sirt1, and Klotho proteins that are linked to longevity. Together, these mechanisms provide support for a role of ASX as a potential geroneuroprotector.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/md18070351
- Canonical
- link ↗
- Fetched
- 2026-10-23 MST
Cite this
APA
Sorrenti, V., Davinelli, S., Scapagnini, G., Willcox, B.J., Allsopp, R., & Willcox, D.C. (2020). Astaxanthin as a Putative Geroprotector: Molecular Basis and Focus on Brain Aging. <em>Marine Drugs</em>. https://doi.org/10.3390/md18070351
Vancouver
Sorrenti V, Davinelli S, Scapagnini G, Willcox BJ, Allsopp R, Willcox DC. Astaxanthin as a Putative Geroprotector: Molecular Basis and Focus on Brain Aging. Marine Drugs. 2020. doi:10.3390/md18070351.
BibTeX
@article{vincenzo2020Astaxa,
title = {Astaxanthin as a Putative Geroprotector: Molecular Basis and Focus on Brain Aging},
author = {Vincenzo Sorrenti and Sergio Davinelli and Giovanni Scapagnini and Bradley J. Willcox and Richard Allsopp and D. Craig Willcox},
journal = {Marine Drugs},
year = {2020},
doi = {10.3390/md18070351},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Frontiers in aging neuroscience 2025
Open access · OA
Editorial: Similarities and differences between cellular and molecular mechanisms of normal brain aging and neurodegeneration.
Nutrients 2026
Open access · CC-BY
Mechanistic Modulation of Autophagy by Bioactive Natural Products: Implications for Human Aging and Longevity
Nutrients 2026
Citation only
Mechanistic Modulation of Autophagy by Bioactive Natural Products: Implications for Human Aging and Longevity.
Frontiers in cardiovascular medicine 2025
Open access · OA
Targeting the hallmarks of aging: mechanisms and therapeutic opportunities.
Nutrients 2026
Open access · CC-BY
Dietary Polyphenols in Brain Aging: Molecular Mechanisms and Implications for Neurodegeneration
Neuroscience 2014
Preprint · OA